| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Pharmacy | 12 | 2024 | 71 | 4.820 |
Why?
|
| Education, Pharmacy | 11 | 2024 | 58 | 4.460 |
Why?
|
| Nonprescription Drugs | 19 | 2018 | 54 | 4.410 |
Why?
|
| Drug Labeling | 12 | 2018 | 30 | 3.400 |
Why?
|
| Health Expenditures | 6 | 2024 | 133 | 2.270 |
Why?
|
| Prescription Drugs | 7 | 2023 | 54 | 2.050 |
Why?
|
| Healthcare Disparities | 4 | 2025 | 487 | 1.930 |
Why?
|
| Pharmacists | 13 | 2013 | 102 | 1.290 |
Why?
|
| United States | 36 | 2025 | 11668 | 1.280 |
Why?
|
| Students | 4 | 2021 | 263 | 1.250 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 482 | 1.230 |
Why?
|
| Cross-Sectional Studies | 26 | 2025 | 3766 | 1.190 |
Why?
|
| Educational Measurement | 6 | 2024 | 330 | 1.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 2092 | 1.090 |
Why?
|
| Adult | 42 | 2025 | 31585 | 0.980 |
Why?
|
| Medicare Part C | 2 | 2016 | 34 | 0.970 |
Why?
|
| School Admission Criteria | 3 | 2023 | 24 | 0.940 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 669 | 0.930 |
Why?
|
| Surveys and Questionnaires | 18 | 2024 | 4003 | 0.880 |
Why?
|
| Curriculum | 3 | 2024 | 772 | 0.880 |
Why?
|
| Schools, Pharmacy | 5 | 2024 | 25 | 0.840 |
Why?
|
| Life Change Events | 2 | 2023 | 65 | 0.830 |
Why?
|
| Chiropractic | 1 | 2023 | 2 | 0.810 |
Why?
|
| Manipulation, Chiropractic | 1 | 2023 | 2 | 0.810 |
Why?
|
| Humans | 82 | 2025 | 132132 | 0.800 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2015 | 79 | 0.800 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2016 | 276 | 0.780 |
Why?
|
| Acetaminophen | 2 | 2015 | 97 | 0.780 |
Why?
|
| Medicare Part D | 2 | 2020 | 13 | 0.780 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 625 | 0.760 |
Why?
|
| Female | 50 | 2025 | 70725 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1408 | 0.750 |
Why?
|
| Perception | 6 | 2016 | 237 | 0.740 |
Why?
|
| Complementary Therapies | 2 | 2013 | 42 | 0.720 |
Why?
|
| Texas | 19 | 2024 | 3630 | 0.720 |
Why?
|
| Male | 47 | 2025 | 64985 | 0.710 |
Why?
|
| Health Status Disparities | 1 | 2024 | 256 | 0.710 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 261 | 0.690 |
Why?
|
| Aged | 26 | 2025 | 21442 | 0.690 |
Why?
|
| Middle Aged | 32 | 2025 | 29003 | 0.680 |
Why?
|
| United States Food and Drug Administration | 9 | 2024 | 160 | 0.680 |
Why?
|
| Health Status Indicators | 2 | 2014 | 128 | 0.680 |
Why?
|
| Self Medication | 5 | 2012 | 21 | 0.670 |
Why?
|
| Attitude of Health Personnel | 5 | 2016 | 724 | 0.670 |
Why?
|
| Diabetes Complications | 1 | 2022 | 207 | 0.670 |
Why?
|
| Retrospective Studies | 16 | 2025 | 17424 | 0.660 |
Why?
|
| Health Status | 3 | 2024 | 408 | 0.660 |
Why?
|
| Health Behavior | 4 | 2017 | 399 | 0.650 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 333 | 0.650 |
Why?
|
| Pharmacy | 1 | 2020 | 19 | 0.650 |
Why?
|
| Cognition | 4 | 2018 | 811 | 0.640 |
Why?
|
| Medication Therapy Management | 2 | 2016 | 23 | 0.630 |
Why?
|
| Universities | 3 | 2018 | 129 | 0.600 |
Why?
|
| Interviews as Topic | 2 | 2018 | 426 | 0.590 |
Why?
|
| Intention | 4 | 2022 | 101 | 0.590 |
Why?
|
| Immunotherapy | 1 | 2024 | 745 | 0.580 |
Why?
|
| Psychological Theory | 3 | 2016 | 37 | 0.570 |
Why?
|
| Quality of Life | 3 | 2015 | 2161 | 0.570 |
Why?
|
| Patient Compliance | 3 | 2015 | 473 | 0.560 |
Why?
|
| Health Services | 1 | 2018 | 69 | 0.560 |
Why?
|
| Medication Adherence | 2 | 2023 | 329 | 0.560 |
Why?
|
| Consumer Behavior | 3 | 2004 | 33 | 0.550 |
Why?
|
| Academic Performance | 1 | 2017 | 25 | 0.550 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 465 | 0.540 |
Why?
|
| Pamphlets | 1 | 2017 | 24 | 0.540 |
Why?
|
| Ephedrine | 2 | 2008 | 5 | 0.540 |
Why?
|
| Reading | 1 | 2018 | 78 | 0.530 |
Why?
|
| Clinical Pharmacy Information Systems | 3 | 2006 | 20 | 0.510 |
Why?
|
| Socioeconomic Factors | 4 | 2025 | 902 | 0.500 |
Why?
|
| Young Adult | 16 | 2024 | 9961 | 0.490 |
Why?
|
| Drug Information Services | 4 | 2004 | 6 | 0.460 |
Why?
|
| Prescription Drug Overuse | 1 | 2015 | 4 | 0.460 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2015 | 123 | 0.450 |
Why?
|
| Medication Systems, Hospital | 4 | 2011 | 45 | 0.450 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 414 | 0.450 |
Why?
|
| Nursing Staff, Hospital | 2 | 2012 | 70 | 0.440 |
Why?
|
| Learning | 1 | 2017 | 370 | 0.430 |
Why?
|
| Social Class | 1 | 2015 | 206 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1538 | 0.420 |
Why?
|
| Formularies as Topic | 2 | 2004 | 2 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2024 | 900 | 0.410 |
Why?
|
| Mental Disorders | 1 | 2021 | 888 | 0.400 |
Why?
|
| Parenting | 1 | 2017 | 349 | 0.390 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 482 | 0.380 |
Why?
|
| Public Opinion | 1 | 2013 | 62 | 0.380 |
Why?
|
| Drugs, Generic | 4 | 2013 | 14 | 0.380 |
Why?
|
| Demography | 2 | 2023 | 241 | 0.380 |
Why?
|
| Consumer Health Information | 1 | 2012 | 29 | 0.380 |
Why?
|
| Achievement | 2 | 2015 | 31 | 0.370 |
Why?
|
| Communication | 1 | 2016 | 543 | 0.370 |
Why?
|
| Professional Role | 5 | 2013 | 73 | 0.370 |
Why?
|
| Stress, Psychological | 1 | 2017 | 577 | 0.360 |
Why?
|
| Efficiency | 1 | 2012 | 67 | 0.360 |
Why?
|
| Exercise | 1 | 2017 | 858 | 0.360 |
Why?
|
| Attitude to Health | 1 | 2013 | 262 | 0.360 |
Why?
|
| Body Mass Index | 1 | 2017 | 1697 | 0.350 |
Why?
|
| Chronic Disease | 1 | 2016 | 1234 | 0.350 |
Why?
|
| Behind-the-Counter Drugs | 1 | 2011 | 1 | 0.350 |
Why?
|
| Education, Pharmacy, Graduate | 2 | 2024 | 7 | 0.350 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 560 | 0.350 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 158 | 0.340 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 116 | 0.340 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 175 | 0.320 |
Why?
|
| Drug and Narcotic Control | 3 | 2019 | 16 | 0.320 |
Why?
|
| Legislation, Drug | 2 | 2008 | 9 | 0.320 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 768 | 0.320 |
Why?
|
| Pharmaceutical Services | 2 | 2016 | 36 | 0.320 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2010 | 36 | 0.310 |
Why?
|
| Health Surveys | 2 | 2008 | 259 | 0.310 |
Why?
|
| Cost of Illness | 1 | 2011 | 285 | 0.310 |
Why?
|
| Hospitalization | 1 | 2018 | 1901 | 0.310 |
Why?
|
| Hematinics | 1 | 2010 | 59 | 0.310 |
Why?
|
| Cystic Fibrosis | 1 | 2011 | 264 | 0.300 |
Why?
|
| Physicians | 6 | 2019 | 642 | 0.290 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 924 | 0.280 |
Why?
|
| Pseudoephedrine | 1 | 2008 | 1 | 0.280 |
Why?
|
| Hydrocodone | 2 | 2019 | 37 | 0.280 |
Why?
|
| Consumer Product Safety | 2 | 2004 | 31 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 2 | 2005 | 89 | 0.270 |
Why?
|
| Drug Packaging | 2 | 2005 | 7 | 0.260 |
Why?
|
| Community Participation | 2 | 2012 | 42 | 0.260 |
Why?
|
| Cohort Studies | 3 | 2024 | 5169 | 0.260 |
Why?
|
| Lymphoma | 1 | 2010 | 331 | 0.250 |
Why?
|
| Drug Prescriptions | 3 | 2006 | 238 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 2 | 2010 | 576 | 0.250 |
Why?
|
| Community Pharmacy Services | 4 | 2013 | 9 | 0.250 |
Why?
|
| Drug Industry | 2 | 2004 | 48 | 0.250 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2006 | 38 | 0.240 |
Why?
|
| Anemia | 1 | 2010 | 350 | 0.240 |
Why?
|
| Language | 1 | 2007 | 226 | 0.240 |
Why?
|
| Medicare | 2 | 2020 | 448 | 0.240 |
Why?
|
| Methamphetamine | 1 | 2006 | 50 | 0.240 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2012 | 9 | 0.240 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 128 | 0.230 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 26 | 0.230 |
Why?
|
| Doping in Sports | 1 | 2005 | 8 | 0.230 |
Why?
|
| Adolescent | 13 | 2018 | 20564 | 0.230 |
Why?
|
| Electronic Health Records | 1 | 2012 | 800 | 0.230 |
Why?
|
| Substance Abuse Detection | 1 | 2005 | 42 | 0.220 |
Why?
|
| Hair Follicle | 1 | 2005 | 35 | 0.220 |
Why?
|
| Motivation | 1 | 2006 | 330 | 0.220 |
Why?
|
| Computers | 1 | 2004 | 70 | 0.210 |
Why?
|
| Marijuana Abuse | 1 | 2024 | 53 | 0.210 |
Why?
|
| Drug Approval | 1 | 2024 | 47 | 0.210 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 13 | 0.210 |
Why?
|
| Blindness | 1 | 2004 | 76 | 0.210 |
Why?
|
| Societies, Pharmaceutical | 1 | 2003 | 14 | 0.210 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 20 | 0.210 |
Why?
|
| Job Satisfaction | 1 | 2004 | 99 | 0.200 |
Why?
|
| Neck Pain | 1 | 2023 | 19 | 0.200 |
Why?
|
| Back Pain | 1 | 2023 | 31 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 172 | 0.200 |
Why?
|
| Heart Diseases | 1 | 2008 | 513 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 471 | 0.200 |
Why?
|
| Prescription Fees | 2 | 2013 | 3 | 0.200 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 329 | 0.200 |
Why?
|
| Comprehension | 2 | 2017 | 81 | 0.200 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2648 | 0.190 |
Why?
|
| Pharmacies | 1 | 2022 | 15 | 0.190 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 171 | 0.190 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 266 | 0.190 |
Why?
|
| Internet | 1 | 2005 | 406 | 0.190 |
Why?
|
| Community Health Centers | 2 | 2012 | 37 | 0.180 |
Why?
|
| Risk | 2 | 2015 | 761 | 0.180 |
Why?
|
| Psychometrics | 2 | 2017 | 686 | 0.180 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 169 | 0.180 |
Why?
|
| Academic Success | 1 | 2021 | 23 | 0.180 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 7108 | 0.170 |
Why?
|
| College Admission Test | 1 | 2020 | 6 | 0.170 |
Why?
|
| Controlled Substances | 2 | 2019 | 11 | 0.170 |
Why?
|
| HIV Infections | 3 | 2014 | 2038 | 0.160 |
Why?
|
| Computers, Handheld | 2 | 2010 | 33 | 0.160 |
Why?
|
| Acute Pain | 1 | 2019 | 17 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2003 | 572 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2016 | 1230 | 0.150 |
Why?
|
| Insurance Coverage | 1 | 2020 | 127 | 0.150 |
Why?
|
| Anxiety | 2 | 2021 | 994 | 0.150 |
Why?
|
| Health Care Surveys | 5 | 2019 | 295 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 3020 | 0.140 |
Why?
|
| Data Collection | 4 | 2007 | 391 | 0.140 |
Why?
|
| Patient Participation | 2 | 2017 | 240 | 0.140 |
Why?
|
| Attitude | 2 | 2012 | 119 | 0.140 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1440 | 0.140 |
Why?
|
| Logistic Models | 3 | 2018 | 1839 | 0.140 |
Why?
|
| Vaccines | 1 | 2022 | 382 | 0.140 |
Why?
|
| Medication Errors | 3 | 2011 | 205 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2004 | 1098 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2019 | 149 | 0.130 |
Why?
|
| Arabs | 1 | 2015 | 30 | 0.120 |
Why?
|
| Nursing Evaluation Research | 2 | 2012 | 7 | 0.120 |
Why?
|
| Watchful Waiting | 1 | 2016 | 77 | 0.120 |
Why?
|
| Tobacco Products | 1 | 2015 | 72 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2011 | 1011 | 0.120 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 486 | 0.110 |
Why?
|
| Forecasting | 1 | 2016 | 372 | 0.110 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 253 | 0.110 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2006 | 50 | 0.110 |
Why?
|
| Choice Behavior | 1 | 1996 | 135 | 0.110 |
Why?
|
| Mammography | 1 | 2015 | 132 | 0.110 |
Why?
|
| Age Factors | 3 | 2015 | 2917 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1460 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2016 | 3739 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2015 | 191 | 0.110 |
Why?
|
| Workflow | 2 | 2011 | 135 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2016 | 416 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2013 | 50 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 392 | 0.090 |
Why?
|
| Diagnosis-Related Groups | 1 | 2012 | 28 | 0.090 |
Why?
|
| Medical Assistance | 1 | 2012 | 6 | 0.090 |
Why?
|
| Time Management | 2 | 2015 | 12 | 0.090 |
Why?
|
| Self Report | 1 | 2015 | 549 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 435 | 0.090 |
Why?
|
| Risk Factors | 2 | 2016 | 10949 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2022 | 14752 | 0.090 |
Why?
|
| Nurses | 1 | 2011 | 74 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2011 | 6571 | 0.080 |
Why?
|
| Educational Status | 2 | 2015 | 294 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 898 | 0.070 |
Why?
|
| Attitude to Computers | 2 | 2010 | 48 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2956 | 0.070 |
Why?
|
| Health Policy | 1 | 2010 | 233 | 0.070 |
Why?
|
| Commerce | 1 | 2008 | 58 | 0.070 |
Why?
|
| Test Anxiety Scale | 1 | 2006 | 2 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 985 | 0.070 |
Why?
|
| Child | 3 | 2022 | 25791 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 231 | 0.060 |
Why?
|
| Length of Stay | 1 | 2012 | 1380 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2016 | 1247 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2010 | 1573 | 0.060 |
Why?
|
| Time and Motion Studies | 3 | 2011 | 22 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 333 | 0.060 |
Why?
|
| Models, Psychological | 2 | 2016 | 143 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 106 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1381 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 113 | 0.060 |
Why?
|
| Poverty | 3 | 2013 | 446 | 0.060 |
Why?
|
| Placebos | 1 | 2005 | 234 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2004 | 32 | 0.050 |
Why?
|
| Social Behavior | 1 | 2006 | 223 | 0.050 |
Why?
|
| Human Genome Project | 1 | 2004 | 56 | 0.050 |
Why?
|
| Spain | 1 | 2004 | 65 | 0.050 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2003 | 3 | 0.050 |
Why?
|
| Diphenhydramine | 1 | 2003 | 12 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2004 | 56 | 0.050 |
Why?
|
| Hospital Information Systems | 1 | 2003 | 44 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 491 | 0.050 |
Why?
|
| Disease Progression | 1 | 2010 | 2226 | 0.050 |
Why?
|
| Home Care Services | 1 | 2003 | 75 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2004 | 200 | 0.050 |
Why?
|
| Bioethics | 1 | 2004 | 77 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 199 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1728 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2003 | 171 | 0.050 |
Why?
|
| Health Services Research | 1 | 2004 | 186 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 182 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1500 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2003 | 136 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 186 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2003 | 143 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2002 | 242 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 103 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1825 | 0.040 |
Why?
|
| Teaching | 1 | 2021 | 200 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2003 | 691 | 0.040 |
Why?
|
| Quality Control | 1 | 1999 | 123 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 280 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 127 | 0.040 |
Why?
|
| Truth Disclosure | 1 | 1999 | 105 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2012 | 453 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 258 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1018 | 0.030 |
Why?
|
| Mental Processes | 1 | 1997 | 39 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2016 | 5 | 0.030 |
Why?
|
| Infant | 1 | 2011 | 13064 | 0.030 |
Why?
|
| Performance Anxiety | 1 | 2015 | 1 | 0.030 |
Why?
|
| Nigeria | 1 | 2015 | 70 | 0.030 |
Why?
|
| Office Visits | 1 | 2016 | 78 | 0.030 |
Why?
|
| Parents | 1 | 2022 | 1079 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 1996 | 92 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2016 | 134 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1170 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2016 | 144 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1996 | 178 | 0.030 |
Why?
|
| Counseling | 1 | 1996 | 238 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 393 | 0.020 |
Why?
|
| Awareness | 1 | 2013 | 80 | 0.020 |
Why?
|
| Nursing Records | 1 | 2011 | 5 | 0.020 |
Why?
|
| Cost Savings | 1 | 2012 | 78 | 0.020 |
Why?
|
| Decision Making | 1 | 1997 | 703 | 0.020 |
Why?
|
| Patient Care | 1 | 2011 | 99 | 0.020 |
Why?
|
| Heart Failure | 1 | 2003 | 2393 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1302 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2012 | 414 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2011 | 422 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 795 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 523 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 589 | 0.020 |
Why?
|
| Telefacsimile | 1 | 2006 | 1 | 0.020 |
Why?
|
| Systems Integration | 1 | 2006 | 28 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2006 | 51 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 686 | 0.010 |
Why?
|
| Home Care Agencies | 1 | 2003 | 1 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6454 | 0.010 |
Why?
|